Exosomes derived from MSC can also reduce myocardial ischemia/reperfusion injury by inducing cardiomyocyte autophagy via AMP-activated protein kinase (AMPK)/mTOR and Akt/mTOR pathways [168]. The gene discussed is MTOR; the disease is myocardial ischemia.